Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fuzheng Jiedu Granules for Acute Upper Respiratory Infection (Wind-Heat with Deficiency)
CTR20170888Phase 2Completed
- Sponsor
- Suzhou Youseen New Drug R&D
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fuzheng jiedu granules in upper respiratory infection (URI), nasopharyngitis, sponsored by Suzhou Youseen New Drug R&D. Started Dec 2017; status: completed.
02
Drugs
fuzheng jiedu granules
03
Conditions
upper respiratory infection (URI)nasopharyngitis
Beyond the preview
Go deeper on CTR20170888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170888.